期刊文献+

基于hNIS基因的辐射正反馈重组杆状病毒体系制备

Preparation of recombinant baculovirus based on the human sodium iodide symporter which participates radiosensitive positive feedback system
下载PDF
导出
摘要 目的构建含早期生长应答因子1(Egr1)辐射敏感启动子调控的人钠碘同向转运体(hNIS)基因重组杆状病毒,为进一步延长核素在细胞中的滞留时间,提高hNIS介导的恶性肿瘤放射性核素基因靶向治疗疗效提供理论基础。方法空载体pFB取自质粒pFB-CMV-EGFP,Egr1启动子取自质粒PGL3-Egr1-luc,hNIS取自质粒pcDNA3.1-CMV-hNIS,构建重组杆状病毒载体质粒pFB-Egr1-Hnis;同时构建含CMV启动子的质粒pFB-CMV-hNIS作为阳性对照,并将杆状病毒空载体质粒pFB-0作为阴性对照。随后制备各组杆状病毒,扩增收集重组杆状病毒并进行滴度测定。为进一步鉴定病毒功能,一方面通过体外感染U87脑胶质瘤细胞并采用131I刺激,通过免疫荧光检测131I刺激后的hNIS蛋白表达;另一方面通过摄碘实验进一步验证所表达的hNIS蛋白的摄碘功能和特性。结果成功构建重组杆状病毒载体质粒pFB-Egr1-hNIS和pFB-CMV-hNIS;转座成功并提取了重组Bacmid;重组Bacmid转染Sf 9细胞后扩增收集的重组杆状病毒滴度可以达到1×1010pfu/mL。体外感染U87细胞后,免疫荧光检测表明131I刺激后可增加hNIS的表达,感染细胞表达的hNIS蛋白位于细胞膜上,且具有摄碘的功能。结论成功构建了重组杆状病毒载体质粒pFB-Egr1-hNIS及pFB-CMV-hNIS,获得高滴度的重组杆状病毒Bac-Egr1-hNIS、Bac-CMV-hNIS和Bac-0并得到验证;建立了基于hNIS基因的辐射正反馈重组杆状病毒体系,为进一步提高核素靶向治疗疗效奠定了重要的理论基础。 Objective To prepare and verify a recombinant baculovirus harboring the human sodium iodide symporter (hNIS) under control of the early growth response-1 (Egr-1) promoter, and to provide the foundation for the research on radionuclides gene targeted treatment of malignant tumors Methods The vector pFB was cut from plasmid pFB-CMV- EGFP; Egrl was cut from plasmid PGL3-Egrl-luc; and hNIS was cut from plasmid pcDNA3, l-CMV-hNIS. Then recombinant baculovirus plasmid pFB-Egrl-hNIS was constructed. In addition, a positive control plasmid pFB-CMV-hNIS and a control plasmid pFB-0 were constructed. Baculovirus Bac-Egrl-hNIS and its controls were prepared, verified, amplified, and collected for trier determination. After glioma cell line U87 was infected with Bac-Egrl-hNIS and exposed to 131 I, the presence and enhanced expression of hNIS protein was tested by immunofluorescence using anti-hNIS antibody. To verify the function of hNIS after 13~ I stimulation, the uptake of iodide was determined after incubation of the processed cells with 125I. Results Recombinant plasmid pFB-Egrl-hNIS, pFB-CMV-hNIS, and pFB-0 were correctly constructed and confirmed by DNA sequencing. Transposition was correct and recombinant Bacmid was extracted. The recombinant baeulovirus were packed, verified, and its titer was about 1 x 1010 Pfu/mL. After incubation with 3 MBq/mL 131I, immunofluorescence showed that the hNIS expression level of Bac-Egrl-hNIS infected U87 cells increased dramatically. In 125 I another side, 131I stimulated U87 cells accumulated more than did non stimulated cells. Conclusion The recombinant baculovirus Bac-Egrl-hNIS and its controls were constructed and verified, and high titer was obtained. This study provides a foundation of radiosensitive positive feedbaek system for further study.
作者 郭睿 李彪
出处 《上海交通大学学报(医学版)》 CAS CSCD 北大核心 2013年第12期1566-1572,共7页 Journal of Shanghai Jiao tong University:Medical Science
基金 国家自然科学基金(81101071) 上海市优秀学科带头人计划项目(11XD1403700) 上海高校青年教师培养资助计划(2011)~~
关键词 人钠碘同向转运体 早期生长应答因子1 重组杆状病毒 正反馈 human sodium iodide symporter early growth response-l recombinant baculovirus positive feedback
  • 相关文献

参考文献11

  • 1Weiss SJ, Philp NJ, Grollman EF. Iodide transport in a continuous line of cultured cells from rat thyroid[J]. Endocrinology, 1984, 114( 4): 1090 - 1098.
  • 2Lau LF, Nathans D. Expression of a set of growth-related immediate early genes in BALBI c 3 T3 cells: coordinate regulation with c-fos or c-rnyc] J]. Proc Nat! Acad Sci USA, 1987, 84 (5): 1182 - 1186.
  • 3张新,李亚明.钠碘转运体的研究进展及其在肿瘤显像和治疗中的应用[J].肿瘤学杂志,2008,14(8):623-626. 被引量:3
  • 4Kogai T, Brent GA. The sodium iodide symporter (NIS): Regulation and approaches to targeting for cancer therapeutics[J]. Pharmacol Ther, 2012, 135 (3) : 355 - 370.
  • 5Venkataraman GM, Yatin M, Marcinek R, et al. Restoration of iodide uptake in dedifferentiated thyroid carcinoma: relationship to human Na + II - symporter gene methylation status]'J].J Clin Endocrinol Metab, 1999, 84 (7) : 2449 - 2457.
  • 6Simon D, Korber C, Krausch M, et al. Clinical impact of retinoid. in redifferentiation therapy of advanced thyroid cancer: final results of a pilot study[J]. EurJ N ucl Med Mol Imaging, 2002, 29 ( 6 ) : 775 -782.
  • 7Hwang MH, Lee SW, KimJE, et al. Enhanced antiproliferative effects of combination hexokinase II shRNA and NIS gene therapy on vascular smooth muscle cells[J]. Nucl Med Bioi, 2012, 39(2): 269 - 278.
  • 8Huang M, Batra RK, Kogai T, et al. Ectopic expression of the thyroperoxidase gene augments radioiodide uptake and retention mediated by the sodium iodide symporter in non-small cell lung cancer[J]. Cancer Gene Ther, 2001, 8(8) : 612 - 618.
  • 9Boland A, Magnon C, Filetti S, et al. Transposition of the thyroid iodide uptake and organification system in nonthyroid tumor cells by adenoviral vector-mediated gene transfers[J]. Thyroid, 2002, 2 (I) : 19 - 26.
  • 10Y oonJK, Park BN, PaikJY, et al. Effects of theophyfline on radio?iodide uptake in MCF -7 breast cancer and NIS gene-transduced SNU -C5 colon cancer cells[J]. Cancer Biother Radiopharm, 2009, 24(2): 201 -208.

二级参考文献29

  • 1Riesco-Eizaguirre G, Santisteban P. A perspective view of sodium iodide symporter research and its clinical implications[J]. Eur 3 Endocrinol, 2006, 155(4):495-512.
  • 2Dai G,Levy O, Carrasco N. Cloning and characterization of the thyroid iodide transporter[J]. Nature, 1996, 379(6564): 458-460.
  • 3Levy O, Dai G, Riedel C, et al. Characterization of the thyroid Na^+/I^- symporter with an anti-COOH terminus antibody[J]. PNAS, 1997, 94(11):5568-5573.
  • 4Eskandari S,Loo DD,Dai G,et al. Thyroid Na^+/I^- symporter. mechanism, stoichiometry, and specificity[J]. J Biol Chem, 1997, 272(43): 27230-27238.
  • 5Van Sande J, Massart C, Beauwens R, et al. Anion selectivity by the sodium iodide symporter [J]. Endocrinology, 2003, 144(1):247-252.
  • 6Wolff J. A miss for NIS? Thyroid[J]. 2002, 12(4):295-297.
  • 7Zuckier LS, Dohan O, Li Y, et al. Kinetics of perrhenate uptake and comparative biodistribution of perrhenate, perteehnetate, and iodide by NaI symporter-expressing tissues in vivo[J]. J Nucl Med, 2004, 45(3):500-507.
  • 8Josefsson M, Grunditz T, Ohlsson T, et al. Sodium/iodide- symporter: distribution in different mammals and role in entero-thyroid circulation of iodide[J]. Acta Physiol Scand, 2002, 175(2):129-137.
  • 9Spitzweg C, Joba W, Schriever K, et al. Analysis of human sodium iodide symporter immunoreactivity in human exocrine glands[J]. J Clin Endocrinol Metab, 1999, 84(11): 4178-4184.
  • 10Tazeday UH, Wapnir IL, Levy O, et al. The mammary gland iodide transporter is expressed during lactation and in breast cancer[J]. Nat Med, 2000, 6(8):871-878.

共引文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部